European Journal of Cancer
Volume 39, Issue 9 , Pages 1216-1221 , June 2003

The level of physical activity in long-term survivors of testicular cancer

  • L. Thorsen

      Affiliations

    • Department and Psychosocial Oncology and Rehabilitation, The Norwegian Radium Hospital, University of Oslo, Oslo 0310, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47-22-93-51-81
    • ,
  • W. Nystad

      Affiliations

    • Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    • ,
  • O. Dahl

      Affiliations

    • Department of Oncology, Hauteland Hospital, Bergen, Norway
    • ,
  • O. Klepp

      Affiliations

    • Department of Oncology, St. Olav's Hospital, Trondheim, Norway
    • ,
  • R.M Bremnes

      Affiliations

    • Department of Oncology, University Hospital, Tromsø, Norway
    • ,
  • E. Wist

      Affiliations

    • Department of Oncology, Ullevål University Hospital Oslo, Norway
    • ,
  • S.D. Fosså

      Affiliations

    • Department of Oncology & Radiotherapy, The Norwegian Radium Hospital, University of Oslo, Norway

Received 9 December 2002 ,Accepted 11 December 2002.

References 

  1. van Basten JP, Schrafford-Koops H, Sleijfer DT, Pras E, van Driel MF, Hoekstra HJ. Current concepts about testicular cancer. Eur. J. Surg. Oncol. 1997;23:354–360
  2. Aass N, Kaasa S, Lund E, Kaalhus O, Heier MS, Fossa SD. Long-term somatic side-effects and morbidity in testicular cancer patients. Br. J. Cancer. 1990;61:151–155
  3. Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J. Clin. Oncol. 1996;14:2923–2932
  4. Arai Y, Kawakita M, Okada Y, Yoshida O. Sexuality and fertility in long-term survivors of testicular cancer. J. Clin. Oncol. 1997;15:1444–1448
  5. Sweeney C. History of testicular cancer chemotherapy (maximizing efficacy, minimizing toxicity). Semin. Urol. Oncol. 2001;19:170–179
  6. Strumberg D, Brugge S, Korn MW, et al.  Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann. Oncol. 2002;13:229–236
  7. Gietema JA, Sleijfer DT, Willemse PH, et al.  Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer. Ann. Intern. Med. 1992;116:709–715
  8. Meinardi MT, Gietema JA, van der Graaf WT, et al.  Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J. Clin. Oncol. 2000;18:1725–1732
  9. Meinardi MT, Gietema JA, van Veldhuisen DJ, van der Graaf WT, de Vries EG, Sleijfer DT. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat. Rev. 2000;26:429–447
  10. Akre O, Ekbom A, Sparen P, Tretli S. Body size and testicular cancer. J. Natl. Cancer Inst. 2000;92:1093–1096
  11. Nord C, Fosså SD, Egeland T. Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer. Br J Cancer. 2003;88:36–41
  12. Bloom JR, Fobair P, Gritz E, et al.  Psychosocial outcomes of cancer (a comparative analysis of Hodgkin's disease and testicular cancer). J. Clin. Oncol. 1993;11:979–988
  13. Douchez J, Droz JP, Desclaux B, et al.  Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors. J. Urol. 1993;149:498–501
  14. Kaasa S, Aass N, Mastekaasa A, Lund E, Fossa SD. Psychosocial well-being in testicular cancer patients. Eur. J. Cancer. 1991;27:1091–1095
  15. Fosså SD, Dahl AA, Loge JH. Fatigue, anxiety and depression in long-term survivors of testicular cancer. J Clin Oncol [in press].
  16. Stender M, Hense HW, Doring A, Keil U. Physical activity at work and cardiovascular disease risk (results from the MONICA Augsburg study). Int. J. Epidemiol. 1993;22:644–650
  17. Holme I, Helgeland A, Hjermann I, Leren P, Lund-Larsen PG. Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study. Acta Med. Scand. 1981;209:277–283
  18. Lochen ML, Rasmussen K. The Tromso study (physical fitness, self reported physical activity, and their relationship to other coronary risk factors). J. Epidemiol. Community Health. 1992;46:103–107
  19. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N. Engl. J. Med. 1997;337:242–253
  20. Blair SN, Haskell WL, Ho P, et al.  Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am. J. Epidemiol. 1985;122:794–804
  21. Lamb KL, Brodie DA. The assessment of physical activity by leisure-time physical activity questionnaires. Sports Med. 1990;10:159–180
  22. Schechtman KB, Barzilai B, Rost K, Fisher E-BJ. Measuring physical activity with a single question. Am J Public Health. 1991;81:771–773
  23. Rauh MJ, Hovell MF, Hofstetter CR, Sallis JF, Gleghorn A. Reliability and validity of self-reported physical activity in Latinos. Int. J. Epidemiol. 1992;21:966–971
  24. Joly F, Heron JF, Kalusinski L, et al.  Quality of life in long-term survivors of testicular cancer (a population-based case-control study). J. Clin. Oncol. 2002;20:73–80
  25. Fossa SD, Aass N, Ous S, Waehre H. Long-term morbidity and quality of life in testicular cancer patients. Scand. J. Urol. Nephrol. Suppl. 1991;138:241–246
  26. Arai Y, Kawakita M, Hida S, Terachi T, Okada Y, Yoshida O. Psychosocial aspects in long-term survivors of testicular cancer. J. Urol. 1996;155:574–578

PII: S0959-8049(03)00151-5

doi: 10.1016/S0959-8049(03)00151-5

European Journal of Cancer
Volume 39, Issue 9 , Pages 1216-1221 , June 2003

Article Tools

* Image Usage & Resolution